Below are the financial statements of Zydus Lifesciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of INR | 2024 | 2023 |
|---|---|---|
| Non-current assets | — | — |
| Property, plant and equipment | 58,033a | 56,965a |
| Capital work-in-progress | 11,115a | 11,302a |
| Goodwill | 52,660a | 48,044a |
| Other intangible assets | 12,992a | 10,200a |
| Intangible assets under development | 13,118a | 705a |
| Investments in joint ventures | 4,162a | 4,166a |
| Financial assets | — | — |
| Investments | 5,518a | 5,107a |
| Loans | 0a | 20a |
| Other financial assets | 577a | 4,980a |
| Deferred tax assets [net] | 16,442a | 12,624a |
| Other non-current assets | 1,969a | 2,162a |
| Assets for current tax [net] | 1,208a | 1,125a |
| Current assets | — | — |
| Inventories | 34,419a | 34,133a |
| Financial assets | — | — |
| Investments | 2,525a | 6,193a |
| Trade receivables | 52,202a | 44,168a |
| Cash and cash equivalents | 4,130a | 4,878a |
| Bank balances other than cash and cash equivalents | 6,921a | 853a |
| Loans | 15a | 4a |
| Other current financial assets | 6,573a | 2,280a |
| Other current assets | 7,413a | 7,573a |
| Assets | — | — |
| Assets classified as held for sale | 816a | 82a |
| Total | 292,808a | 257,564a |
| Equity | — | — |
| Equity share capital | 1,006a | 1,012a |
| Other equity | 197,289a | 174,146a |
| Equity and liabilities | — | — |
| Equity attributable to equity holders of the parent | 198,295a | 175,158a |
| Non-controlling interests | 22,721a | 21,725a |
| Financial liabilities | — | — |
| Borrowings | 0a | 0a |
| Lease liabilities | 251a | 198a |
| Other financial liabilities | 10,542a | 514a |
| Non-current liabilities | — | — |
| Provisions | 3,097a | 2,718a |
| Deferred tax liabilities [net] | 4,465a | 1,944a |
| Other non-current liabilities | 18a | 0a |
| Financial liabilities | — | — |
| Borrowings | 7,686a | 11,632a |
| Lease liabilities | 105a | 119a |
| Trade payables | — | — |
| Dues to micro and small enterprises | 670a | 377a |
| Dues to other than micro and small enterprises | 20,597a | 20,873a |
| Current liabilities | — | — |
| Other financial liabilities | 13,891a | 14,339a |
| Other current liabilities | 2,780a | 2,705a |
| Provisions | 3,948a | 3,654a |
| Current tax liabilities [net] | 3,720a | 1,568a |
| Liabilities directly associated with assets classified as held for sale | 22a | 40a |
| Total | 292,808a | 257,564a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Zydus Lifesciences’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.